Catalog touch agent cheese pharmaceutical company or change commission system

In recent years, people from all walks of life have a lot of disputes about the role of pharmaceutical agents Since the introduction of the basic medicine catalogue (the basic part) in the middle of August, the focus of public opinion has generally focused on the impact on hospitals and pharmaceutical enterprises In fact, the special group of agents is no less concerned about the catalog than the first two Industry insiders said that the introduction of some catalogues will reduce the sales volume of agents within 30% of the grassroots pilot market or by more than 50% Therefore, the important response of agent Zui is to form a united front with the enterprise, to ensure winning the bid, to actively strive for "supplement" varieties of the catalogue, and even the situation that pharmaceutical enterprises may implement "commission system" management on agents Rural market: sales volume may be halved, said Ming Ruiqin, agent of Jiangxi Antai Pharmaceutical Co., Ltd., Zui's major target market affected by the catalogue is agents in rural and community medical institutions "Especially if the target market is within the 30% pilot range, the sales volume may be reduced by more than 50%." Mingruiqin stressed that even if the agent's products enter the catalog, they can't be happy too early Even if the sales volume increases after the national unified pricing, it's difficult to guarantee profits According to Yang Changshun, marketing department of Shanghai Haihong Jinchen Pharmaceutical Co., Ltd., there are 27 varieties of traditional Chinese medicine in 102 kinds of Chinese patent medicines, including 26 manufacturers There are 22 kinds of traditional Chinese Medicine * dosage forms, covering 22 production enterprises The agents of these * variety enterprises will undoubtedly be the big beneficiaries of Zui Although the competition is more and more fierce and the state's policy intervention is more and more strong, the position of agents will not disappear Yang Changshun revealed that in the pharmaceutical chain, the agent is a grey invisible person, and they play a role in promoting the operation of all links More than half of China's pharmaceutical companies do not have their own marketing team, so agents are essential Market: the market may shrink Yang Changshun believes that doctors can easily evade the policy without other measures They only need to add a basic drug based on the existing prescription In this way, the target agent sales in the market will be separated from each other in various games Only when the comprehensive supporting measures are gradually implemented can the sales volume of essential drugs really "blowout" Regardless of the proportion of basic drugs used in secondary and tertiary hospitals, it will affect the market Therefore, the agents in the target market will face the possibility of market shrinkage in the future Han Yonggang, an agent in Hubei Province, said that in the future, agents will definitely increase the products in the catalogue of essential drugs Agents: we hope to supplement the catalogue In addition, although the opinions on further standardizing the centralized purchase of drugs in medical institutions jointly signed by the Ministry of health and other six departments changed the "bidding by wholesale enterprises" to "direct bidding by drug manufacturers", in fact, the bidding is often done by agents The content of "supplement" in the implementation opinions of the national essential drug system also gives a glimmer of hope to the agents whose products are not included in the catalogue Han Yonggang predicted that the "supplement" part would account for about 5% of the total drugs, and local governments would leave more opportunities to local enterprises He even thought that after the government loosened the gap, perhaps in addition to the supplement, the grass-roots "full allocation" might also be loosened according to the local government's financial situation He also said that after the medical reform, the team of agents will gradually concentrate, not excluding the possibility of several large agents monopolizing the market and small agents gradually withdrawing